Show
Sort by
-
- Journal Article
- A1
- open access
Molecular imaging of tumor-associated angiogenesis using a novel magnetic resonance imaging contrast agent targeting αvβ3 integrin
-
Cisplatin-modified de Gramont in second-line therapy for pancreatic adenocarcinoma
-
Standardized added metabolic activity (SAM) IN 18F-FDG PET assessment of treatment response in colorectal liver metastases
-
Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake?
-
Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model
-
- Journal Article
- A1
- open access
Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members
-
Cisplatin-modified de Gramont in second line therapy for pancreatic adenocarcinoma
-
Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases
-
99mTc-labeled tricarbonyl His-CNA35 as an imaging agent for the detection of tumor vasculature
-
An evaluation of FDG-PET as a predictor of metabolic response to chemotherapy in metastatic colorectal cancer patients (mCRC)
-
In vivo imaging of apoptosis in oncology : an update
-
99mTc-(CO)3 His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab
-
- Conference Paper
- C3
- open access
Efficacy of the combined use of bevacizumab and irinotecan in a human colorectal cancer xenograft model analysed by SPECT imaging
-
Postoperative outcome in patients with intraductal papillary mucinous neoplasia of the pancreas and pancreatic neuroendocriene tumors
-
- Conference Paper
- C3
- open access
FDG-PET is a predictor of metabolic response to chemotherapy in metastatic colorectal cancer (mCRC)
-
- Conference Paper
- C3
- open access
Preoperative chemotherapy for colorectal liver metastases : prediction of response by DCE-MRI abd FDG-PET/CT?
-
- Conference Paper
- C3
- open access
PET as a predictor of metabolic response to antiangiogenic therapy in metastatic colorectal cancer (mCRC)
-
Antitumour efficacy of two paclitaxel formulations for hyperthermic intraperitoneal chemotherapy (HIPEC) in an in vivo rat model
-
Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights
-
Monoclonal anti-EGFR antibodies in the treatment of nonresectable metastatic colorectal cancer patients : a literature review
-
Noninvasive monitoring of therapy-induced microvascular changes in a pancreatic cancer model using dynamic contrast-enhanced magnetic resonance imaging with P846, a new low-diffusible gadolinium-based contrast agent
-
In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells
-
SPECT imaging of apoptotic tumor response in a colorectal tumor model
-
Assessment and prognostic vaule of regression after neoadjuvant therapy in rectal cancer: the role of tumor shrinkage and fragmentation
-
- Journal Article
- A1
- open access
Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas
-
The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model
-
- Journal Article
- A2
- open access
Haalbaarheid van een georganiseerde screening naar colorectaal carcinoom in de laag risicopopulatie
-
Low molecular weight heparin inhibits tumor associated angiogenesis in vivo
-
MOLECULAR IMAGING OF TUMOR ASSOCIATED ANGIOGENESIS USING P1227, A NOVEL MRI CONTRAST AGENT TARGETING AVB3 INTEGRIN
-
Low molecular weight heparin inhibits tumor associated angiogenesis in vivo
-
Defining the optimal therapy sequence in synchronous respectable liver metastases from colorectal cancers: a decision analysis approach
-
PET evaluation of anti-VEGF treatment in combination with chemotherapy in MCRC
-
Diffusion magnetic resonance imaging as surrogate marker to anti-VEGF treatment response in MCTC
-
Comparison of two contrast agents for DCE-MRI evaluation of anti-VEGF treatment in combination with chemotherapy in MCRC
-
Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: An experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy
-
Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma
-
Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasis
-
Gene expression differentiates liver metastases from isolated peritoneal metastases in colorectal cancer
-
Microsatellite instability in Belgian sporadic colon carcinomas has no independent prognostic value in a Belgian study population
-
Advances in the management of gastrointestinal stromal tumours
-
Expression of SGLT1 and Bcl-2 in pancreatic cancer and their metastases related to survival
-
Effects of the low molecular weight heparin nadroparin on tumor associated angiogenesis
-
The role of oral fluoropyrimidines in the treatment of advanced gastric cancer
-
Molecular imaging of tumor associated angiogenesis uzing P1127, a novel MRI contrast agent targeting alfa V beta 3 integrin
(2008) -
Functionele beeldvorming van respons op anti-angiogene therapie
(2008) Up to date. -
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival
-
- Journal Article
- A1
- open access
Detection of microsatellite instability in colorectal cancer using an alternative multiplex assay of quasi-monomorphic mononucleotide markers
-
Molecular imaging of tumor associated angiogenesis using P1227, a noval MRI contrast agent targeting Alfa V Beta 3 integrin
-
Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population
-
Investigation of the EGFR and K-RAS gene status in squamous cell carcinoma of the anal canal
-
Effects of the low molecular weight heparin nadroparin on tumour associated angiogenesis
-
Expression of hexokinase II in pancreatic cancer predicts survival
-
Expression of SGLT1 and Bcl-2 in panreatic cancer and their metastases related to survival.
-
Evaluation of EGFR and K-RAS gene status in squamous cell carcinoma of the anal canal.
-
Differential gene expression between metastatic colorectal tumours in liver and peritoneum.
-
Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) with 3 different contrast agents for therapy monitoring in a tumour bearing mouse model.
-
Is combined F-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography superior to Positron Emission Tomography or Computed Tomography alone for diagnosis, staging and restaging of pancreatic lesions ?
-
Converging expression profiles from esophageal and colorectal cancer tissues: a comparative analysis using expression microarray.
-
Converging expression profiles from oesophageal and colorectal cancer tissues: a comparative analysis using expression microarray.
-
Squamous cell carcinoma of the anus: a possible target for EGFR inhibition?
-
Assessment of therapy response by DCE-MRI with a macromolecular gadolinium contrast agent.
-
Recombinant human erythropoietin α modulates the effects of radiotherapy on colorectal cancer microvessels
-
Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer
-
Neoadjuvant chemoradiation versus hyperfractionated accelerated radio-therapy (HART) in respectable dital rectal cancer
-
Ki-67 and von Willebrand factor: outcome predictors for oesophageal cancer
-
Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy (HART) in resectable distal rectal cancer
-
Use of PET/CT in pancreatic lesions
-
Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy (HART) in resectable distal rectal cancer
-
Are von Willebrand factor and Ki-67 outcome predictors for esophageal cancer?
-
- Journal Article
- A1
- open access
Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model
-
Limited influences of chemotherapy on healthy and metastatic liver parenchyma
-
Voedingstoestand bij kanker
-
In vivo mapping of the effects of radiotherapy on neovascular permeability using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI)
-
In vivo mapping of the effects of radiotherapy on neovascular permeability using dynamic contrast enhanced MRI
-
Effect of rh EPO on tissue oxygen and flow mapping: experimental study in a rat colorectal cancer model
-
Limited influences of chemotherapy on healthy and metastatic liver parenchyma from colorectal cancer
-
Routine microsatellite instability testing in sporadic colorectal tumours
-
Limited influences of chemotherapy on healthy and metastatic liver parenchyma from colorectal cancer
-
Limited influences of chemotherapy on healthy and metastatic liver parenchyma from colorectal cancer
-
De rol van visvetzuren bij kanker cachexie
-
Influences of chemotherapy on healthy and metastatic liver parenchyma is limited
-
Changes in rheumatoid factor reflect the inflammatory response (CRP and ESR) to infliximab treatment
-
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy
-
Fish dentitions as paradigms for odontogenic questions
-
Influence of the gut and cytokine patterns in spondyloarthropathy.
-
Increase in lymphoid follicles and leukocyte adhesion molecules emphasizes a role for the gut in spondyloarthropathy pathogenesis.
-
Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy.
-
Phenotypical and functional characterisation of human intestinal lymphocytes from patients with spondyloarthropathy
(2001) -
Immunomodulatory effects of anti-tumor necrosis factor α therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study
-
The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome.
-
Gut mucosal T cell lines from ankylosing spondylitis patients are enriched with alpha E beta 7 integrin.
-
Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFα
-
Flow cytometric analysis of gut mucosal lymphocytes supports an impaired Th1 cytokine profile in spondyloarthropathy.
-
Focal up-regulation of E-cadherin-catenin complex in inflamed bowel mucosa but reduced expression in ulcer associated cell lineage.
-
Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex.
-
Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity
-
Chemical agents and enzymes used for the extraction of gut lymphocytes influence flow cytometric detection of T cell surface markers.
-
Opportunities for immune modulation in the spondyloarthropathies with special reference to gut inflammation.
-
Crohn's disease and ulcerative colitis show different distribution patterns of CD83 positive dendritic cells
-
T cell cytokines in gut mucosa of patients with spondyloarthropathy reflect immune alterations in Crohn's disease
-
Inflammatory bowel disease and subclinical gut inflammation in spondyloarthropathy patients are associated with increased expression of the E-cadherin/catenin complex
-
Intestinal mucosa of patients with spondyloarthropathy is enriched with T cells carrying alpha E beta 7 integrin, even in the absence of histologically defined inflammation
-
Effects of chemical agents and enzymes on lymphocyte surface markers
-
Inflammatory bowel disease and subclinical gut inflammation in spondyloarthropathy patients are associated with increased expression of the E-cadherin/catenin complex
-
Upregulation of E-cadherin and associated molecules (a-, ß- and y-catenins) in inflamed bowel mucosa
-
Increased expression of E 7 integrin in uninflamed mucosa of patients with spondyloarthropathy
-
Effects of chemical agents and enzymes on the detection of lymphocyte surface markers.
-
Isolation of colonie mucosal lamina propria and intra-epithelial lymphocytes : mechanical versus enzymatic isolation
-
Altered expression of ocEß7 integrin on intra-epithelial and lamina propria lymphocytes in patients with Crohn's disease
-
A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers.